Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout
Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout the European Union.
The 5-lb unit allows for color power Doppler capability and uses digital broadband beam-forming technology. SonoSite received 510(k) clearance from the Food and Drug Administration for SonoSite 180 in April (SCAN 4/28/99) for such indications as gynecology, obstetrics, and abdominal imaging. The system is configured to offer both transabdominal and intravaginal imaging, according to SonoSite.
In other SonoSite news, the company has joined Office of the Future, a research and development consortium that is working to create a clinical office model that integrates technology, information, and design. The group plans to use SonoSite 180 in the exam and procedure rooms it is developing. Office of the Future includes such companies as Midmark, American Express Healthcare Finance, American Medical Development, GE Marquette Medical Systems, Health Care Data Systems, Hewlett-Packard, Lunar, and Sony Electronics Medical Systems.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.